We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sanofi Sa | LSE:0A2V | London | Ordinary Share | SANOFI ADR REP 1 1/2 ORD (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 328 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 43.07B | 5.4B | 4.2694 | 21.38 | 0 |
TIDM0A2V
RNS Number : 2548K
Societe Generale SA
20 April 2020
Date: 20/04/2020
Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.
SANOFI - Stabilisation Notice
Societe Generale (Contact: DUANE ELGEY; telephone: +44-20-7676-7650) hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilising Manager(s) named below in relation to the offer of the following securities.
Issuer: SANOFI ======================================= ======================================== Guarantor (if any): n/a ======================================= ======================================== Aggregate Nominal Amount: EUR 750m | EUR 750m ======================================= ======================================== Description: Maturity: 1(st) April 2025 | 1(st) April 2030 Coupon: 1% | 1.5% ======================================= ======================================== Offer price: 99.723 | 99.283 --------------------------------------- ----------------------------------------
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
STAPPURACUPUGAU
(END) Dow Jones Newswires
April 20, 2020 12:01 ET (16:01 GMT)
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions